Belite Bio BLTE
NASDAQ BLTE
$162.98 -6.84 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Accumulated Expenses (2021 - 2025)

Updated

Belite Bio (BLTE) recorded Accumulated Expenses of $9.64 million in Q4 2025, up 67.3% from $5.76 million a year earlier and up 23.6% from the prior quarter.

Analysis

Belite Bio (BLTE) Accumulated Expenses (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Belite Bio's Accumulated Expenses history includes 6 quarters.

  • Annual Accumulated Expenses has increased for four straight years, with a four-year compound annual growth rate of 57.5% (FY2021 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $5.76 million in FY2024 (+73.3%), $3.33 million in FY2023 (+74.4%), $1.91 million in FY2022 (+21.9%) and $1.56 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Belite Bio 6.68 Bn 6.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 9.64 Mn
Sep 30, 2025 7.79 Mn
Dec 31, 2024 5.76 Mn
Dec 31, 2023 3.33 Mn
Dec 31, 2022 1.91 Mn
Dec 31, 2021 1.56 Mn
API Access

Belite Bio Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BLTE&period=max&api_key=YOUR_API_KEY